Literature DB >> 15361656

Human and mouse hematopoietic colony-forming cell assays.

Cindy L Miller1, Becky Lai.   

Abstract

Hematopoietic stem cells present in small numbers in certain fetal organs during development and in adult bone marrow produce a heterogeneous pool of progenitors that can be detected in vitro using colony-forming cell (CFC) assays. Hematopoietic progenitor cells, when cultured in a semisolid methylcellulose-based medium that is supplemented with suitable growth factors, proliferate and differentiate to produce clonal clusters (colonies) of maturing cells. The CFCs are then classified and enumerated in situ by light microscopy. Protocols for the detection and enumeration of myeloid multipotential progenitors and committed progenitors of the erythroid, monocyte, and granulocyte lineages in samples from human peripheral blood, bone marrow, and cord blood as well as mouse fetal liver and bone marrow are described.

Entities:  

Mesh:

Year:  2005        PMID: 15361656     DOI: 10.1385/1-59259-838-2:071

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  In vitro assays misrepresent in vivo lineage potentials of murine lymphoid progenitors.

Authors:  Lauren I Richie Ehrlich; Thomas Serwold; Irving L Weissman
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

2.  Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.

Authors:  Caryn S Gonsalves; Chen Li; Marthe-Sandrine Eiymo Mwa Mpollo; Vinod Pullarkat; Punam Malik; Stanley M Tahara; Vijay K Kalra
Journal:  Biochem J       Date:  2015-04-16       Impact factor: 3.857

3.  Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 Transcript.

Authors:  Louis R Ghanem; Andrew Kromer; Ian M Silverman; Xinjun Ji; Matthew Gazzara; Nhu Nguyen; Gabrielle Aguilar; Massimo Martinelli; Yoseph Barash; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

4.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.

Authors:  Mervin C Yoder; Laura E Mead; Daniel Prater; Theresa R Krier; Karim N Mroueh; Fang Li; Rachel Krasich; Constance J Temm; Josef T Prchal; David A Ingram
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

5.  Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

Authors:  Marcos de Lima; Ian McNiece; Simon N Robinson; Mark Munsell; Mary Eapen; Mary Horowitz; Amin Alousi; Rima Saliba; John D McMannis; Indreshpal Kaur; Partow Kebriaei; Simrit Parmar; Uday Popat; Chitra Hosing; Richard Champlin; Catherine Bollard; Jeffrey J Molldrem; Roy B Jones; Yago Nieto; Borje S Andersson; Nina Shah; Betul Oran; Laurence J N Cooper; Laura Worth; Muzaffar H Qazilbash; Martin Korbling; Gabriela Rondon; Stefan Ciurea; Doyle Bosque; Ila Maewal; Paul J Simmons; Elizabeth J Shpall
Journal:  N Engl J Med       Date:  2012-12-13       Impact factor: 91.245

6.  Clonal analysis of hematopoietic progenitor cells in the zebrafish.

Authors:  David L Stachura; Ondrej Svoboda; Ryan P Lau; Keir M Balla; Leonard I Zon; Petr Bartunek; David Traver
Journal:  Blood       Date:  2011-03-17       Impact factor: 22.113

7.  Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.

Authors:  Esther Drent; Richard W J Groen; Willy A Noort; Maria Themeli; Jeroen J Lammerts van Bueren; Paul W H I Parren; Jürgen Kuball; Zsolt Sebestyen; Huipin Yuan; Joost de Bruijn; Niels W C J van de Donk; Anton C M Martens; Henk M Lokhorst; Tuna Mutis
Journal:  Haematologica       Date:  2016-02-08       Impact factor: 9.941

8.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

9.  MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen.

Authors:  Katja Fiedler; Enikö Kokai; Susanne Bresch; Cornelia Brunner
Journal:  Am J Blood Res       Date:  2013-05-05

10.  BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.

Authors:  Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Elena Deych; Matthew S Holt; Julie K Ritchey; John F DiPersio
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.